Acute 5-HT2C Receptor Antagonist SB-242084 Treatment Affects EEG Gamma Band Activity Similarly to Chronic Escitalopram

dc.contributor.author	Papp, Noémi
dc.contributor.author	Koncz, Szabolcs
dc.contributor.author	Kostyalik, Diána
dc.contributor.author	Kitka, Tamás
dc.contributor.author	Petschner, Péter
dc.contributor.author	Vas, Szilvia
dc.contributor.author	Bagdy, György
dc.date.accessioned	2020-07-25T16:00:43Z
dc.date.available	2020-07-25T16:00:43Z
dc.date.issued	2020
dc.identifier	85079373486
dc.identifier.citation	journalVolume=10;pagination=Paper 1636, 9 Pages; journalTitle=FRONTIERS IN PHARMACOLOGY;journalAbbreviatedTitle=FRONT PHARMAC;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/8401
dc.identifier.uri	doi:10.3389/fphar.2019.01636
dc.title	Acute 5-HT2C Receptor Antagonist SB-242084 Treatment Affects EEG Gamma Band Activity Similarly to Chronic Escitalopram
dc.type	Journal Article
dc.date.updated	2020-07-25T14:34:43Z
dc.language.rfc3066	en
dc.rights.holder	NULL
dc.identifier.mtmt	31155226
dc.identifier.wos	000514917200001
dc.identifier.pubmed	32063851
dc.contributor.department	SE/GYTK/Gyógyszerhatástani Intézet
dc.contributor.department	SE/GYTK/GYHATAS/MTA-SE Neuropszichofarmakológiai és Neurokémiai Kutatócsoport
dc.contributor.department	SE/GYTK/GYHATAS/NAP-2-SE Új Antidepresszív Gyógyszercélpont Kutatócsoport
dc.contributor.institution	Semmelweis Egyetem
dc.mtmt.swordnote	Department of Pharmacodynamics, Semmelweis University, Budapest, Hungary MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Budapest, Hungary Department of Physiology, Development, and Neuroscience, University of Cambridge, Cambridge, United Kingdom NAP-2-SE New Antidepressant Target Research Group, Budapest, Hungary Export Date: 21 April 2020 Correspondence Address: Bagdy, G.; Department of Pharmacodynamics, Semmelweis UniversityHungary; email: bag13638@iif.hu